Cephalosporin Market Report by Generation (First Generation, Second Generation, Third Generation, Fourth Generation, Fifth Generation), Route of Administration (Injection, Oral), Application (Respiratory Tract, Skin Infection, Ear Infection, Urinary Tract Infection, Sexually Transmitted Infection, and Others), and Region ​2025-2033​

Cephalosporin Market Report by Generation (First Generation, Second Generation, Third Generation, Fourth Generation, Fifth Generation), Route of Administration (Injection, Oral), Application (Respiratory Tract, Skin Infection, Ear Infection, Urinary Tract Infection, Sexually Transmitted Infection, and Others), and Region ​2025-2033​

Report Format: PDF+Excel | Report ID: SR112025A1359

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Cephalosporin Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Breakup by Generation
    5.5    Market Breakup by Route of Administration
    5.6    Market Breakup by Application
    5.7    Market Breakup by Region
    5.8    Market Forecast
6   Market Breakup by Generation
    6.1    First Generation
        6.1.1    Market Trends
        6.1.2    Market Forecast
    6.2    Second Generation
        6.2.1    Market Trends
        6.2.2    Market Forecast
    6.3    Third Generation
        6.3.1    Market Trends
        6.3.2    Market Forecast
    6.4    Fourth Generation
        6.4.1    Market Trends
        6.4.2    Market Forecast
    6.5    Fifth Generation
        6.5.1    Market Trends
        6.5.2    Market Forecast
7   Market Breakup by Route of Administration
    7.1    Injection
        7.1.1    Market Trends
        7.1.2    Market Forecast
    7.2    Oral
        7.2.1    Market Trends
        7.2.2    Market Forecast
8   Market Breakup by Application
    8.1    Respiratory Tract
        8.1.1    Market Trends
        8.1.2    Market Forecast
    8.2    Skin Infection
        8.2.1    Market Trends
        8.2.2    Market Forecast
    8.3    Ear Infection
        8.3.1    Market Trends
        8.3.2    Market Forecast
    8.4    Urinary Tract Infection
        8.4.1    Market Trends
        8.4.2    Market Forecast
    8.5    Sexually Transmitted Infection
        8.5.1    Market Trends
        8.5.2    Market Forecast
    8.6    Others
        8.6.1    Market Trends
        8.6.2    Market Forecast
9   Market Breakup by Region
    9.1    Asia Pacific
        9.1.1    Market Trends
        9.1.2    Market Forecast
    9.2    Europe
        9.2.1    Market Trends
        9.2.2    Market Forecast
    9.3    North America
        9.3.1    Market Trends
        9.3.2    Market Forecast
    9.4    Middle East and Africa
        9.4.1    Market Trends
        9.4.2    Market Forecast
    9.5    Latin America
        9.5.1    Market Trends
        9.5.2    Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Analysis
    13.1    Price Indicators
    13.2    Price Structure
    13.3    Margin Analysis
14  Competitive Landscape
    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Allergan Plc.
        14.3.2    Bristol-Myers Squibb Company
        14.3.3    F. Hoffmann-La Roche Ltd.
        14.3.4    GlaxoSmithKline plc
        14.3.5    Lupin Limited
        14.3.6    Merck & Co. Inc.
        14.3.7    Novartis International AG (Sandoz)
        14.3.8    Pfizer Inc.
        14.3.9    Sanofi
        14.3.10    Teva Pharmaceutical Industries Ltd.
        14.3.11     Abbott
        14.3.12    Sun Pharmaceutical Industries Limited

List of Figures

Figure 1: Global: Cephalosporin Market: Major Drivers and Challenges
Figure 2: Global: Cephalosporin Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Cephalosporin Market: Breakup by Generation (in %), 2024
Figure 4: Global: Cephalosporin Market: Breakup by Route of Administration (in %), 2024
Figure 5: Global: Cephalosporin Market: Breakup by Application (in %), 2024
Figure 6: Global: Cephalosporin Market: Breakup by Region (in %), 2024
Figure 7: Global: Cephalosporin Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 8: Global: Cephalosporin (First Generation) Market: Sales Value (in Million USD), 2019 & 2024
Figure 9: Global: Cephalosporin (First Generation) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: Cephalosporin (Second Generation) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Cephalosporin (Second Generation) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Cephalosporin (Third Generation) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Cephalosporin (Third Generation) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Cephalosporin (Fourth Generation) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Cephalosporin (Fourth Generation) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Cephalosporin (Fifth Generation) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Cephalosporin (Fifth Generation) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Cephalosporin (Injection) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Cephalosporin (Injection) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Cephalosporin (Oral) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Cephalosporin (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Cephalosporin (Respiratory Tract) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Cephalosporin (Respiratory Tract) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Cephalosporin (Skin Infection) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Cephalosporin (Skin Infection) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: Cephalosporin (Ear Infection) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: Cephalosporin (Ear Infection) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Global: Cephalosporin (Urinary Tract Infection) Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: Global: Cephalosporin (Urinary Tract Infection) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: Global: Cephalosporin (Sexually Transmitted Infection) Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: Global: Cephalosporin (Sexually Transmitted Infection) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: Global: Cephalosporin (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: Global: Cephalosporin (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: Asia Pacific: Cephalosporin Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: Asia Pacific: Cephalosporin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: Europe: Cephalosporin Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: Europe: Cephalosporin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: North America: Cephalosporin Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: North America: Cephalosporin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: Middle East and Africa: Cephalosporin Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: Middle East and Africa: Cephalosporin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: Latin America: Cephalosporin Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: Latin America: Cephalosporin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: Global: Cephalosporin Industry: SWOT Analysis
Figure 45: Global: Cephalosporin Industry: Value Chain Analysis
Figure 46: Global: Cephalosporin Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Cephalosporin Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Cephalosporin Market Forecast: Breakup by Generation (in Million USD), 2025-2033
Table 3: Global: Cephalosporin Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
Table 4: Global: Cephalosporin Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 5: Global: Cephalosporin Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 6: Global: Cephalosporin Market Structure
Table 7: Global: Cephalosporin Market: Key Players

Cephalosporin Market Report by Generation (First Generation, Second Generation, Third Generation, Fourth Generation, Fifth Generation), Route of Administration (Injection, Oral), Application (Respiratory Tract, Skin Infection, Ear Infection, Urinary Tract Infection, Sexually Transmitted Infection, and Others), and Region ​2025-2033​
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials